SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001387131-20-006774
Filing Date
2020-07-27
Accepted
2020-07-27 17:19:53
Documents
1
Group Members
DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND II, L.P.DECHENG CAPITAL MANAGEMENT II (CAYMAN), LLCDECHENG CAPITAL MANAGEMENT III (CAYMAN), LLCXIANGMIN CUI

Document Format Files

Seq Description Document Type Size
1 ACQUISITION OF BENEFICIAL OWNERSHIP bysi-sc13d_071520.htm SC 13D 200121
  Complete submission text file 0001387131-20-006774.txt   201855
Mailing Address 28 LIBERTY STREET 39TH FLOOR NEW YORK NY 10005
Business Address 28 LIBERTY STREET 39TH FLOOR NEW YORK NY 10005 646-528-4184
BeyondSpring Inc. (Subject) CIK: 0001677940 (see all company filings)

IRS No.: 463009483 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90237 | Film No.: 201051149
SIC: 2834 Pharmaceutical Preparations

Mailing Address UGLAND HOUSE, PO BOX 309 GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, PO BOX 309 GRAND CAYMAN E9 KY1-1104 345-949-8066
Decheng Capital China Life Sciences USD Fund III, L.P. (Filed by) CIK: 0001736814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D